NLE Gastrointestinal Nursing — Nutritional & Metabolic SupportStudy Notes

Comprehensive nutritional assessment is the first step in identifying patients who need nutritional support. In the Philippine healthcare context, where both obesity and malnutrition remain significant public health burdens, accurate assessment is essential. The assessment integrates three domains: anthropometric (body measurements), biochemical (laboratory values), and clinical/dietary findings. **Anthropometric Assessment:** Body Mass Index (BMI) is calculated using the formula: **BMI = weight (kg) ÷ height (m²)**. This is a universal screening tool, though interpretation differs by ethnicity. The World Health Organization (WHO) standard categories are: underweight <18.5 kg/m², normal weight 18.5–24.9 kg/m², overweight 25–29.9 kg/m², and obese ≥30 kg/m². However, for Asian populations—including Filipinos—the cut-offs are lower because cardiometabolic risk rises earlier in this ethnic group. The revised Asian cut-offs are: overweight ≥23 kg/m² and obese ≥27.5 kg/m². This is particularly important in Filipino clinical practice, where many patients with a BMI of 25–27 already show insulin resistance and metabolic syndrome markers. Unintentional weight loss is also critical to document. Significant weight loss is defined as >5% in one month or >10% in six months; this indicates nutritional decline and requires intervention. **Biochemical Assessment:** Serum albumin and prealbumin (transthyretin) are protein markers that reflect nutritional status, but they have different timelines. Albumin has a long half-life of approximately 3 weeks, making it a marker of chronic (long-term) nutritional status. Prealbumin, with a half-life of only 2 days, is more sensitive to recent intake changes and is preferred for monitoring short-term nutritional responses. Additionally, assess serum transferrin, total lymphocyte count, and electrolyte panels (sodium, potassium, phosphate, magnesium, calcium). Micronutrient screening includes vitamin D, vitamin B12, folate, iron studies, and zinc levels, especially in high-risk groups (bariatric surgery patients, chronic GI disease, alcoholism). **Clinical and Dietary Assessment:** Observe for visible signs of malnutrition: muscle wasting (loss of temporalis and supraclavicular folds), edema (which may mask weight loss in protein-deficient states), dry/dull hair, pale mucous membranes, and angular cheilitis. Document oral intake history—what, how much, and how often the patient can eat—and functional status (ability to feed self, chewing/swallowing ability). This holistic approach aligns with the NCM (Nursing Care Manual) framework and supports the nursing process of assessment leading to diagnosis and planning.

Obesity in the Philippines is increasing among both urban and rural populations due to dietary shifts (increased processed foods), reduced physical activity, and genetic predisposition. Obesity is defined as excess adiposity with BMI ≥30 kg/m² (or ≥27.5 for Asians). It results from energy intake exceeding energy expenditure over time, influenced by genetic factors (20–30% heritability), behavioral patterns (eating habits, sedentary lifestyle), and environmental factors (food accessibility, urbanization). **Health Consequences:** Obesity significantly raises the risk of type 2 diabetes mellitus, hypertension, dyslipidemia, coronary artery disease, obstructive sleep apnea (OSA), non-alcoholic fatty liver disease (NAFLD), osteoarthritis (weight-bearing joints), and several cancers (breast, colon, endometrial). Many obese Filipino patients present with metabolic syndrome—a cluster of abdominal obesity, hypertension, dysglycemia, and dyslipidemia—increasing cardiovascular mortality risk. Understanding these complications is essential for comprehensive care planning and patient education. **Management Approach (Evidence-Based Ladder):** 1. **First-line:** Sustained caloric deficit (500–1000 kcal/day below expenditure = ~0.5–1 kg/week weight loss) combined with physical activity (aerobic + resistance training) and behavioral modification (mindfulness, habit change, support groups). This is the safest, most sustainable approach. 2. **Second-line:** Pharmacotherapy for select patients (BMI ≥30 with comorbidities, or ≥27 if Asian). Common agents include **orlistat** (pancreatic lipase inhibitor; reduces fat absorption by 30%), and **GLP-1 receptor agonists** such as **liraglutide** and **semaglutide** (enhance satiety, slow gastric emptying, improve insulin sensitivity). These require close monitoring and are not first-line in all resource-limited Philippine settings. 3. **Third-line:** Bariatric surgery (sleeve gastrectomy, Roux-en-Y gastric bypass) for **BMI ≥40** or **BMI ≥35 with obesity-related comorbidities**. This is increasingly available in major Philippine hospitals and addresses severe obesity when medical therapy fails. **Nursing Role in Obesity Management:** The nurse is instrumental in screening for obesity-related comorbidities (blood pressure, fasting glucose, lipid panel, sleep apnea screening via STOP-BANG questionnaire). Set realistic, achievable goals—rapid weight loss is unsustainable and often leads to rebound weight gain. Promote gradual, consistent changes (e.g., 30 minutes of brisk walking 5 days/week, replacing sugary drinks with water). Critically, **avoid weight stigma and bias**. Research shows that weight-stigmatizing interactions reduce patient engagement in health-seeking behaviors and worsen outcomes. Apply non-judgmental, weight-inclusive language and support the patient's intrinsic motivation for health behavior change, not appearance-based goals.

Malnutrition is a state of inadequate nutrient intake leading to altered body composition and function. It ranges across a spectrum from acute, total energy deficit (marasmus—severe wasting without edema, common in famines or extreme poverty) to protein-deficit states (kwashiorkor—with edema and preserved weight due to fluid accumulation, historically seen in protein-restricted diets). In contemporary Philippine hospitals, **mixed malnutrition** is most common—patients with chronic underlying disease (chronic kidney disease, cancer, chronic obstructive pulmonary disease) who develop acute illness (pneumonia, sepsis, surgery) and reduce their oral intake, resulting in both energy and protein depletion. **Clinical Manifestations:** Malnutrition presents with unintentional weight loss, visible muscle wasting (depleted temporalis, supraclavicular fossae, quadriceps), generalized weakness and fatigue, pale/cool extremities, and slow wound healing (due to impaired collagen synthesis and immune function). Edema may appear in protein-deficient states, and patients often report poor appetite or early satiety. Micronutrient deficiencies compound the picture: anemia (iron, B12, folate deficiency), impaired immunity (increased susceptibility to infections, including opportunistic organisms), and specific signs (night blindness from vitamin A deficiency, petechiae from vitamin C deficiency). **Assessment Criteria for Malnutrition (ASPEN/IFPEN Guidelines):** Screening triggers include: (1) BMI <18.5 kg/m² (or recent drop from baseline), (2) unintentional weight loss >5% in 1 month or >10% in 6 months, (3) reduced oral intake for >2 weeks, (4) low serum prealbumin (<20 mg/dL) or albumin (<3.5 g/dL), and (5) clinical signs (muscle wasting, edema). In Philippine settings with limited laboratory access, clinical assessment (weight trend, visible muscle loss, functional decline) combined with dietary history guides diagnosis. **Management Strategy (Nutritional Rehabilitation):** 1. **Identify and treat the underlying cause:** resolve infections, optimize chronic disease management, address psychological factors (depression, anorexia nervosa). Without this, nutrition support fails. 2. **Oral route first:** Whenever the gut functions and the patient can swallow safely, use oral feeding. Offer **small, frequent, energy- and protein-dense meals** (e.g., milk-based puddings, peanut butter, eggs, fish). Supplement with **oral nutritional supplements** (e.g., local brands like **Nutri-Joy**, **Ensure**, **Resource**) between meals if intake remains inadequate. These are cost-effective in Philippine primary care settings. 3. **Add enteral nutrition** only if oral intake remains <60–75% of requirements despite optimal encouragement. Tube feeding bypasses swallowing and delivers nutrition reliably. 4. **Add parenteral nutrition** only as a last resort when the gut is truly non-functional (e.g., post-major bowel resection, severe pancreatitis). 5. **Monitor for refeeding syndrome** (see next section) if the patient is severely malnourished. **NANDA Nursing Diagnoses in Malnutrition:** - **Imbalanced Nutrition: Less Than Body Requirements** (related to inadequate intake, impaired absorption, or increased metabolic demand) - **Ineffective Health Maintenance** (related to lack of knowledge about nutritious foods, food insecurity) - **Risk for Infection** (related to compromised immune function from protein-energy malnutrition) - **Delayed Wound Healing** (related to protein deficit and micronutrient deficiency) **Nursing Interventions (Aligned with RA 9173 Scope):** - Conduct thorough dietary assessment and identify barriers (financial, cultural, medical—dysphagia, early satiety from gastric cancer). - Teach the importance of protein and energy intake; provide culturally appropriate meal planning (e.g., using local, affordable foods: rice, legumes, eggs, tinapa—dried fish). - Monitor weight trends weekly; adjust interventions if weight loss continues. - Coordinate with a registered dietitian for formal nutrition care (available in most hospital settings in the Philippines). - Address psychosocial factors; depression and food insecurity often underlie malnutrition in vulnerable populations.

Refeeding syndrome is a potentially fatal metabolic complication that occurs when nutrition is reintroduced to a severely malnourished patient, especially if feeding is aggressive. This concept is **high-yield for the NLE** and critical for safe practice. **Pathophysiology:** When a chronically starved patient is fed, the sudden influx of carbohydrate (primarily dextrose in TPN or tube feeds) triggers an **insulin surge**. Insulin shifts the body's metabolism from catabolic (breaking down) to anabolic (building up). This metabolic shift drives **electrolytes intracellularly** as cells take up phosphate, potassium, and magnesium to synthesize ATP, proteins, and other molecules. The result is severe **HYPOphosphatemia, HYPOkalemia, and HYPOmagnesemia** in the serum. Additionally, prolonged starvation depletes total-body **thiamine (vitamin B1)** stores, and refeeding without thiamine supplementation can precipitate **Wernicke encephalopathy** (confusion, ophthalmoplegia, ataxia). **Clinical Manifestations:** The first 24–72 hours of refeeding are highest-risk. Signs include: - **Cardiac:** arrhythmias (from hypokalemia and hypophosphatemia), sudden cardiac death - **Respiratory:** respiratory muscle weakness (from hypophosphatemia) leading to respiratory failure - **Neurologic:** confusion, seizures (from hypomagnesemia), peripheral neuropathy (from thiamine deficiency) - **Metabolic:** hyperglycemia (insulin resistance in early malnutrition), fluid retention and pulmonary edema (rapid IV feeding) **Prevention: The "START LOW AND SLOW" Principle** 1. **Identify high-risk patients:** BMI <16 kg/m², unintentional weight loss >10% in 6 months, serum albumin <3.0 g/dL, or prolonged fasting (>10 days). 2. **Give thiamine 100–200 mg IV or IM daily for at least 3 days before and during nutritional repletion** (or give it with the first meal). This prevents Wernicke encephalopathy. 3. **Start feeding LOW:** Provide only 25–50% of estimated caloric needs on day 1, increase gradually by 25% daily as tolerated, reaching full requirements over 4–7 days. For example, if a patient needs 2000 kcal/day, start with 500–1000 kcal/day and increase by 500 kcal/day. 4. **Monitor electrolytes closely:** Measure serum phosphate, potassium, magnesium on day 1, then daily for 5–7 days. **Correct deficits aggressively** (e.g., IV potassium and phosphate replacement). Many hospitals in the Philippines stock IV potassium and magnesium solutions; ensure these are available before refeeding begins. 5. **Monitor blood glucose:** Hyperglycemia is common initially; use sliding-scale insulin or insulin infusion as needed. 6. **Maintain adequate hydration** without overloading (risk of pulmonary edema). 7. **Monitor clinical status:** daily weights, fluid balance (I&O), cardiac rhythm monitoring if possible, and neurologic checks for confusion or seizure activity. **NLE-Style Knowledge:** The NLE often asks: "A severely malnourished 50-year-old patient is admitted and nutrition support is initiated. Which complication is MOST likely in the first 72 hours?" The answer involves recognizing **refeeding syndrome** and its metabolic derangements (HYPOphosphatemia, HYPOkalemia, HYPOmagnesemia) as the priority threat. Questions may also ask about management: "Before refeeding, which vitamin should be given first?" Answer: **thiamine (vitamin B1).** Or: "What is the recommended feeding rate for a severely malnourished patient on day 1?" Answer: **25–50% of estimated needs.**

Enteral nutrition—delivering nutrition directly into the gastrointestinal tract via a tube—is the **preferred route whenever the gut works**. The adage "**if the gut works, use it**" encapsulates a core nutritional principle: enteral feeding is superior to parenteral nutrition because it maintains intestinal integrity, stimulates immune function via gut-associated lymphoid tissue (GALT), is more physiologic, is less expensive, and carries fewer infectious and metabolic complications. Understanding enteral nutrition is essential for daily nursing practice in Philippine hospitals and clinics. **Routes of Enteral Feeding:** 1. **Short-term (days to weeks, typically <4 weeks):** - **Nasogastric tube (NGT):** passed through the nose, down the esophagus, and into the stomach. Quick to place, reversible, suitable for conscious patients with intact swallow reflex (to protect airway) and functioning stomach. - **Nasointestinal (nasojejunal or nasoduodenal):** tube placed beyond the pylorus, bypassing the stomach. Used when gastric feeding is not tolerated (post-op patients with delayed gastric emptying, pancreatitis, aspiration risk despite gastric feeding). 2. **Long-term (weeks to months, typically >4 weeks):** - **Percutaneous endoscopic gastrostomy (PEG):** tube placed endoscopically through the abdominal wall directly into the stomach. Gold standard for long-term feeding; allows normal bolus feeding and medication administration. Common in stroke patients, advanced dementia, head/neck cancer requiring prolonged support. - **Surgical gastrostomy/jejunostomy:** direct surgical placement into the stomach or small bowel; used when PEG is contraindicated (e.g., gastric cancer, anatomic obstruction). Jejunostomy allows continuous feeding in patients at high aspiration risk. **Verification of Tube Placement: A Critical Safety Step** Before administering EVERY feed or medication, verify that the tube is in the correct location. This is non-negotiable; inadvertent administration into the lung or peritoneal cavity can cause catastrophic harm. - **Gold standard:** **Chest/abdominal X-ray** (shows the tube tip location). Verify initial placement with imaging. - **Bedside methods:** **Aspirate gastric contents** and test with **pH indicator**. Gastric pH is ≤5.5 (acidic); if pH >6, the tube may be in the lung or small bowel. Note that pH testing is not 100% reliable, especially if the patient is on acid-suppressing medications. - **Auscultation (air insufflation)** is **unreliable alone** and should not be the only verification method; it can produce similar sounds whether air enters the stomach or lung. - **Visual inspection** of aspirate is also unreliable; bile-stained (green) aspirate suggests intestinal placement, but gastric contents can also appear greenish. - **Repeat verification:** If there is any doubt—after a prolonged period, after vomiting or coughing, or after tube repositioning—verify placement again. **Preventing Aspiration: The Highest Priority** Aspiration (entry of tube-fed formula into the lungs) is the most serious enteral feeding complication, potentially causing aspiration pneumonia, respiratory compromise, or death. Prevention strategies: 1. **Head of bed (HOB) elevation:** Maintain **30–45° elevation during feeding and for 30–60 minutes after feeding stops**. This uses gravity to keep gastric contents flowing distally and prevents backup into the esophagus and lungs. 2. **Check gastric residual volume (GRV):** Before each bolus feeding and every 4–6 hours during continuous feeding, withdraw gastric contents via the tube. GRV >250–500 mL (exact threshold varies by institutional protocol; many Philippine hospitals use 200 mL) suggests delayed gastric emptying or inadequate absorption; hold the feed, keep the patient NPO, and notify the physician. Elevate HOB further. Consider prokinetic medications (metoclopramide, domperidone) or post-pyloric (jejunal) feeding if gastric feeding persistently fails. 3. **Position the patient:** Right lateral decubitus position (if tolerated and not contraindicated) promotes gastric emptying. 4. **Use appropriate tube size and placement:** Smaller tubes (8–12 Fr for nasogastric, smaller for post-pyloric) cause less esophageal irritation and reduce reflux. Post-pyloric (small-bowel) placement intrinsically lowers aspiration risk. 5. **Monitor respiratory status:** Watch for signs of aspiration (cough, fever, crackles on lung auscultation, hypoxia, new infiltrate on chest X-ray). Report immediately. **Tube Care and Maintenance:** - **Flush the tube:** Before and after **every bolus feeding** and **every medication administration**, flush with 20–30 mL of sterile water using a syringe (or 50 mL of water if a pump is used for continuous feeding every 4–6 hours). This prevents clogging. - **Medications:** Give medications separately, each flushed with water. **Do not crush enteric-coated tablets** (which are designed to dissolve in the small bowel, not the stomach) or **sustained-release (SR/ER) medications** (crushing destroys the timed-release mechanism and may cause toxicity). If the drug cannot be given as a liquid or swallowed tablet, consult the pharmacist or physician for alternatives. - **Formula hang time:** For **open systems** (not pre-filled bag systems), use formula within **4–8 hours** of opening (varies by institutional policy; follow your hospital's protocol). Discard unused formula. Store unopened cans in a cool place; opened formula is refrigerated for no more than 24 hours. - **Tube care:** Daily assessment for signs of tube obstruction (high resistance to flushing), migration (aspirate volume changes, tube marking at the nostril changes), or local irritation (nasal erythema, nasal congestion). Secure the tube to the cheek or forehead with transparent tape or commercial tube holder to prevent movement. **Enteral Formulas: Matching Formula to Patient** Formulas vary by composition, osmolality, and therapeutic use: 1. **Polymeric (intact protein) formulas:** Standard choice for most patients with functioning gut and intact absorptive capacity. Examples: **Ensure**, **Resource**, **Nutren**. These contain whole proteins, carbohydrates, and fats; normal osmolality (~300–350 mOsm/kg) and typically well-tolerated. 2. **Elemental (predigested) and semi-elemental formulas:** For patients with impaired digestion or absorption (short-bowel syndrome, pancreatic insufficiency, Crohn's disease, post-chemotherapy). Proteins are broken down to amino acids or dipeptides; easier to absorb but more expensive. Osmolality is often higher (hyperosmolar), so start slowly and advance gradually to avoid diarrhea. 3. **Disease-specific formulas:** - **Renal formula:** Low electrolytes (potassium, phosphate, sodium), controlled protein (lower nitrogen load), for chronic kidney disease. - **Hepatic formula:** Enriched branched-chain amino acids (BCAAs), reduced aromatic amino acids, for hepatic encephalopathy risk. - **Diabetic formula:** Lower simple carbohydrates, higher fat and protein, to minimize glycemic spikes. - **Pulmonary formula:** Higher fat, lower carbohydrate (reduces CO₂ production), for COPD or respiratory failure. 4. **Fiber-containing vs. fiber-free:** Fiber may help regulate bowel function and lower diarrhea risk, but is withheld if there is severe ileus or risk of obstruction. Many Philippine patients tolerate and benefit from fiber-containing formulas. **Delivery Methods:** 1. **Bolus (intermittent) feeding:** 200–400 mL given by syringe or gravity every 4–6 hours (4–6 times daily). Most physiologic, closest to normal meals, suitable for gastric feeding and alert patients. Risk: rapid gastric distension and possible aspiration if HOB not maintained. 2. **Continuous feeding:** Formula infused by pump over 20–24 hours per day. Better tolerated in post-op patients, small-bowel feeding, or patients with high residuals on bolus. Risk: less physiologic, requires pump (cost and training), risk of continuous glucose delivery and hyperglycemia. Transition to bolus feeding as patient improves. **Complications of Enteral Feeding (and Nursing Management):** 1. **Aspiration pneumonia (most serious):** Keep HOB 30–45° during and after feeding; check GRV; verify tube placement; monitor respiratory status. 2. **Diarrhea:** Often from hyperosmolar formula, rapid feeding rate, lactose intolerance, or concurrent antibiotics. Manage by: slowing the infusion rate, diluting formula (if it was concentrated), switching to a fiber-containing formula, and reviewing medications (some antibiotics cause C. difficile-associated diarrhea, requiring specific treatment). 3. **Tube obstruction/clogging:** Flush regularly with water; use liquid medications where possible; avoid crushing pills. If obstructed, try flushing with warm water, then coca-cola (high acid and carbonation, anecdotally effective) or use commercially available declogging solutions. If unsuccessful, tube replacement may be needed. 4. **Tube migration or malposition:** The tube may move (patient pulls it out, patient vomits and tube is displaced, tube advances into the small bowel). Verify placement if GRV changes or patient vomits; order imaging if concerned. 5. **Dumping syndrome (rare with slow, appropriate feeding):** rapid emptying of hyperosmolar formula → cramping, diarrhea, nausea, palpitations, sweating. Manage by slowing infusion rate and ensuring formula osmolality is appropriate. 6. **Metabolic complications:** hyperglycemia (especially if formula contains high dextrose or patient has diabetes), hyperlipidemia (if formula is very high-fat), dehydration if intake is inadequate, or fluid overload if continuous feeding is excessive. Monitor glucose, lipids, and fluid balance. **Transition from Tube Feeding to Oral Intake:** As the patient recovers and can safely swallow (confirmed by swallow assessment), gradually increase oral intake while decreasing tube feeding. Typically, reduce tube feeding by 25% when the patient is reliably taking 25% of needs orally; continue this pattern until oral intake is sufficient (usually ≥75–80% of needs) and the patient is maintaining weight. Then discontinue the tube feed and monitor for continued tolerance. This gradual transition reduces the risk of inadequate nutrition or rebound aspiration.

Total Parenteral Nutrition (TPN) delivers **complete nutrition intravenously**—bypassing the gastrointestinal tract entirely. It is a **last-resort modality, reserved for patients whose GI tract cannot be safely used** for >7–10 days. TPN is expensive, carries significant infection risk, and causes metabolic complications; therefore, it is used only when enteral feeding is truly impossible or has failed. This is a **high-yield, safety-critical NLE topic** with specific rules that must be memorized. **Indications for TPN (When the Gut Cannot Work):** 1. **Massive bowel resection or short-bowel syndrome:** Loss of >70% of small-bowel length, leaving insufficient absorptive surface. These patients may eventually adapt (over months to years), but nutrition support is needed immediately. 2. **Prolonged complete ileus:** Post-operative (major GI surgery, abdominal trauma) with expected NPO >7–10 days; neurologic ileus (spinal cord injury, autonomic dysfunction). 3. **Severe acute pancreatitis:** Enteral feeding risks triggering pancreatic inflammation; TPN is withheld to rest the pancreas, though enteral feeding to the distal duodenum or jejunum (post-pyloric) is increasingly preferred even in pancreatitis if tolerated. 4. **High-output fistula:** GI fistula losing >500 mL/day of nutrient-rich fluid. Once the fistula output stabilizes and enteral feeding can be resumed, TPN is weaned. 5. **Intractable vomiting:** From obstruction, gastroparesis, or chemotherapy, unresponsive to anti-emetics and unable to be bypassed by post-pyloric feeding tube placement. 6. **Severe malabsorption (short-term support):** While awaiting resolution (e.g., post-chemotherapy mucositis), though enteral feeding is resumed as soon as possible. **Composition of TPN:** TPN is a **3-in-1 admixture** or delivered as separate components (less common now). Standard TPN contains: - **Dextrose (carbohydrate):** 15–35% concentration (typical 20–25%). This is the **high-osmolality component** that mandates central-line administration. - **Amino acids (protein):** 3–15% concentration, adjusted for renal/hepatic function. - **Lipid emulsion:** 10–20%, providing fat-soluble vitamins (A, D, E, K) and essential fatty acids. Often given as a 24-hour continuous infusion to avoid hypertriglyceridemia. - **Electrolytes:** sodium, potassium, chloride, magnesium, calcium, phosphate (composition tailored to patient labs). - **Vitamins:** multivitamins (water-soluble B vitamins, C), fat-soluble vitamins (A, D, E, K). - **Trace elements:** zinc (critical for wound healing), copper, chromium, manganese, selenium. - **Additives:** heparin (anticoagulation in the line), insulin (sliding-scale for glycemic control), medications in some instances. **Central Venous Access: Non-Negotiable** - TPN must be infused through a **central venous line** (subclavian, internal jugular, or PICC—peripherally inserted central catheter). The **hyperosmolar dextrose concentration** (20–35%) would cause **sclerosis (vein damage) if infused into a peripheral vein**, resulting in pain, phlebitis, and tissue necrosis. - In contrast, a **lower-concentration peripheral PN** (10% dextrose, reduced amino acids, no lipids) can be given peripherally for **short-term use only (≤7 days)**; this is not TPN but "peripheral PN" and is rarely used in contemporary practice. - **Central-line complications:** infection (catheter-related bloodstream infection, **CRBSI**, the most common TPN complication), thrombosis, malpositioning, and mechanical complications (pneumothorax during insertion, air embolism during tubing changes). **Administration: Safety-Critical Rules (Memorize These)** 1. **Use an infusion PUMP (not gravity):** - TPN is delivered via **volumetric infusion pump** on a consistent, physician-ordered rate (e.g., 50 mL/hour). This maintains steady glucose delivery and prevents metabolic derangement. - **Do NOT adjust the pump rate to "catch up" if the infusion fell behind**, and **do NOT slow the rate to extend the infusion**. Maintaining the prescribed rate is critical for blood glucose stability. - If the next TPN bag is not ready or there is a delay, **hang 10% dextrose (D10W) intravenously at the same rate as the TPN was ordered** to prevent rebound hypoglycemia. Never substitute plain saline or other non-dextrose fluids. 2. **NEVER stop TPN abruptly (this is a frequent NLE question):** - During TPN infusion, the pancreas is exposed to high-glucose stimulus and continues secreting insulin even as glucose infusion wanes. Abrupt cessation → **sudden loss of exogenous glucose while insulin continues secreting → REBOUND HYPOGLYCEMIA** (blood glucose can drop to dangerous levels within 1–2 hours). - **Management:** Taper the TPN rate down over several hours (e.g., reduce from full rate to 50% rate for 1 hour, then 25% rate for 1 hour, then discontinue). Continue **blood-glucose monitoring during and for 4–6 hours after discontinuation** to detect rebound hypoglycemia. If hypoglycemia develops (glucose <70 mg/dL), treat with IV dextrose or oral carbohydrate and hold the discontinuation. 3. **Strict aseptic technique:** - TPN is an **ideal culture medium for bacteria and fungi**; infection rates are highest among all IV therapies. - **Before hanging:** use sterile gloves, mask, and alcohol-based skin antiseptic (70% alcohol or 2% chlorhexidine). - **Tubing changes:** per protocol (typically every 24 hours; some institutions use 48 hours). Tubing is changed with the TPN bag. - **Dressing changes:** per protocol (typically every 7 days or when damp/soiled). Use sterile technique; some centers use transparent, permeable dressings to allow daily visual inspection for erythema or drainage. 4. **Dedicated line:** - **The TPN line is for TPN only** (with rare exceptions for specific assignments by physicians, e.g., a dedicated lumen in a multi-lumen PICC). - **Do NOT infuse other IV medications through the TPN line** (risk of incompatibility and precipitation; many drugs bind to lipids in TPN). - **Do NOT draw blood samples from the TPN line** (risk of introducing contamination and losing venous access). - **Do NOT measure central venous pressure (CVP)** via the TPN line unless explicitly ordered and the line is not actively infusing TPN. - This dedication minimizes the risk of infection and mechanical compromise. **Monitoring TPN (Daily, at Minimum):** - **Weight:** daily, same time of day, same scale (track trends; unexplained weight gain may indicate fluid accumulation). - **Fluid intake and output (I&O):** precise record. TPN is typically hyperosmolar and draws fluid intracellularly; monitor urine output (goal >1500 mL/day or 0.5 mL/kg/hour) and insensible losses. - **Blood glucose:** Check fasting glucose and via finger-stick every 4–6 hours initially. Hyperglycemia is common in the first 24–48 hours (insulin deficiency in malnourished state, stress hyperglycemia); controlled by sliding-scale insulin or insulin infusion. Goal is usually 140–180 mg/dL in hospital; tight control (<110 mg/dL) increases hypoglycemia risk without clear outcome benefit. - **Serum electrolytes, phosphate, magnesium:** Initial labs on day 1 and day 2, then 2–3 times weekly once stable. TPN bags are customized based on labs; communicate any abnormalities to the nutrition team immediately. - **Liver function tests (ALT, AST, bilirubin, albumin):** Weekly. Long-term TPN (>2 weeks) can cause hepatic steatosis and cholestasis; withholding lipids temporarily or switching to a lower-lipid formula may help. - **Triglycerides:** Weekly if lipids are infused; goal <250 mg/dL. Elevated triglycerides increase pancreatitis risk; reduce lipid dose or space infusion over longer hours if elevated. - **Albumin/prealbumin:** Weekly or bi-weekly to track nutritional repletion. - **Presence of catheter-related blood stream infection (CRBSI):** Clinical signs include **fever (often >38.5°C), chills, tachycardia, or hypotension** without other obvious source. **Blood cultures (drawn from central line and a peripheral line for comparison) and CBC** are obtained. If CRBSI is suspected, the line may need removal and replacement at a new site. This is the most common infectious complication of TPN. **Metabolic Complications:** 1. **Rebound hypoglycemia:** Abrupt cessation (managed by tapering and D10W substitution, discussed above). 2. **Refeeding syndrome:** If TPN is initiated in a severely malnourished patient without precautions (start low and slow, thiamine, monitor electrolytes, see section 4). 3. **Hyperglycemia and hyperlipidemia:** From high dextrose and lipid content; managed by insulin and dose adjustment. 4. **Hepatic steatosis and cholestasis:** With prolonged TPN use (>2 weeks); reduced by cycling TPN (infusing for 12–18 hours/day rather than 24 hours, allowing periods of rest) and limiting lipid dose. 5. **Bone disease:** Long-term TPN can cause osteoporosis and metabolic bone disease; vitamin D, calcium, and periodic imaging may be needed. **Transitioning Off TPN:** As the GI tract recovers, enteral or oral feeding is advanced, and TPN is weaned. Typically, reduce TPN by 25% each day (or every 12 hours, depending on protocol) while increasing enteral intake by a similar amount. Continue blood-glucose monitoring through the transition. Discontinue TPN when the patient is reliably taking ≥75–80% of nutritional needs orally or enterally. This gradual transition avoids rebound hypoglycemia and prevents nutritional deficit.

Bariatric (weight-loss) surgery is offered for severe obesity when medical and behavioral therapies fail. In the Philippines, bariatric surgery is increasingly available in tertiary hospitals in Metro Manila and major cities, reflecting rising obesity rates and improved surgical access. Understanding post-operative nursing care, immediate complications, dietary progression, and long-term micronutrient deficiencies is essential for clinical practice and the NLE. **Indications for Bariatric Surgery:** - **BMI ≥40 kg/m²** (or ≥37.5 for Asians in some guidelines) with or without comorbidities. - **BMI ≥35 kg/m² (or ≥32.5 for Asians) WITH obesity-related comorbidities** such as type 2 diabetes, hypertension, sleep apnea, or fatty liver disease. - **Failed medical therapy:** documented attempts at sustained weight loss via diet, exercise, and/or pharmacotherapy for ≥6 months. - **Psychological readiness:** patient understands the surgery, is committed to lifelong dietary changes, and has no untreated psychiatric conditions. **Common Surgical Procedures:** 1. **Sleeve gastrectomy:** Removal of 70–80% of the stomach, creating a narrow "sleeve" along the greater curvature. Restrictive only (no malabsorption); relatively quick recovery; commonly performed in the Philippines. 2. **Roux-en-Y gastric bypass:** Creation of a small pouch from the proximal stomach, then connection directly to the jejunum (bypassing the duodenum and proximal ileum). Restrictive + malabsorptive; greater weight loss but higher nutritional deficiency risk. 3. **Biliopancreatic diversion:** More extensive; rarely done in the Philippines due to higher complexity and complication risk. **Post-Operative Nursing Priorities (Immediate: First 24–72 Hours):** 1. **Monitor for anastomotic leak (most serious early complication):** - An anastomotic leak is a breach in the surgical suture line, allowing gastric/intestinal contents to spill into the peritoneal cavity → peritonitis, sepsis, shock, death. - **Early signs (within 24–48 hours):** **tachycardia (HR >100), fever (>38.5°C), **rising abdominal pain** (worsening, not improving), **restlessness/anxiety, tachypnea, and hypotension**. These are **ominous signs** and require immediate physician notification and urgent imaging (abdominal CT with contrast) and possible return to the OR. - **Prevention/early detection:** Keep the patient NPO immediately post-op; if the surgical team orders oral intake (clear liquids at 24 hours, then advancing), start SLOWLY and watch for any sign of intolerance. Maintain nasogastric decompression if a tube is placed. Monitor vital signs and pain closely. 2. **Airway management and sleep apnea precautions:** - Many bariatric patients have **obstructive sleep apnea (OSA)** (estimated 50–80% of severe obesity patients), which increases anesthesia and post-operative respiratory complication risk. - Keep the head of bed **elevated 30–45°** even immediately post-op to ease breathing. - Use incentive spirometry; encourage early ambulation (typically 6–12 hours post-op, with assistance). - Monitor oxygen saturation continuously; use supplemental oxygen if SpO₂ <92%. - If OSA is known, the patient may be on CPAP; resume CPAP as soon as feasible (within 24 hours) if tolerated. 3. **Venous thromboembolism (VTE) prevention:** - Bariatric patients are at **high risk for deep vein thrombosis (DVT) and pulmonary embolism (PE)** due to immobilization, post-operative inflammation, and possibly hypercoagulability from obesity. - **Mechanical prophylaxis:** sequential compression devices on the legs (on immediately pre-op, continued until patient is fully mobile). - **Pharmacologic prophylaxis:** subcutaneous heparin (enoxaparin 40–60 mg once daily) or LMWH, typically started 12–24 hours post-op (timing depends on bleeding risk and surgeon preference). - **Early ambulation:** mobilize within 6–12 hours post-op if hemodynamically stable; this is the single most important prevention strategy. - **Monitor for signs of DVT (unilateral leg swelling, pain, warmth) and PE (chest pain, dyspnea, tachycardia)**; report immediately if suspected. 4. **Pain management:** - Post-op pain is expected. Use multimodal analgesia: acetaminophen, NSAIDs (if not contraindicated), and opioids as needed. Many surgeons avoid NSAIDs initially (theoretically increase anastomotic leak risk, though evidence is weak). - Encourage ambulation and breathing exercises; splint the incision with a pillow if coughing to reduce pain and support the surgical site. 5. **Fluid and electrolyte management:** - Initially, the patient receives IV fluids (after NPO period, usually 4–6 hours post-op). Monitor urine output and vital signs. - Once clear liquids are tolerated (usually 24 hours post-op), begin advancement: clear liquids → full liquids → soft/pureed diet → normal diet (over 4–8 weeks). - Small, frequent amounts: 20–30 mL of clear liquid every 2 hours initially, advancing to 100–150 mL per meal as tolerated. **Dietary Progression and Dumping Syndrome Prevention:** **Dumping syndrome** is a very common post-bariatric surgery complication, especially after gastric bypass. It results from **rapid gastric emptying** of **hyperosmolar food** (especially simple carbohydrates and sugar) into the small bowel, causing osmotic fluid shift and neurohormonal responses. **Symptoms (occur 15–30 minutes after eating):** - **GI:** cramping, abdominal pain, nausea, diarrhea, bloating. - **Vasomotor:** palpitations, tachycardia, sweating, flushing, dizziness or presyncope. - **Neurologic:** weakness, difficulty concentrating. **Patient Teaching to Prevent/Minimize Dumping Syndrome:** - **Eat small, frequent meals:** 4–6 meals per day, 100–200 mL (3–7 oz) per meal initially, advancing as tolerated. - **Avoid simple carbohydrates and sugar:** No candy, soda, desserts, sweetened fruits, honey. These are hyperosmolar and trigger dumping. In the Philippines, educate patients to avoid sugared drinks (which are culturally common) and sweets. - **Eat more protein and fat:** These are absorbed more slowly, minimizing gastric dumping. Include eggs, fish, chicken, cheese, nuts (in small amounts). - **Separate eating and drinking:** Drink fluids **between meals, not with meals**. This reduces gastric volume and slows emptying. Sip small amounts of water 30 minutes after eating. - **Lie down after eating:** Horizontal position slows gastric emptying; patient should rest for 15–30 minutes after meals. - **Chew food thoroughly:** Small particles empty more slowly, reducing osmotic load. - **Monitor tolerance:** Some patients tolerate certain foods better; a food diary helps identify triggers. **Lifelong Nutritional Complications and Supplementation (Critical for Long-Term Care):** Bariatric surgery, especially bypass procedures, creates **anatomic malabsorption**. Post-operative patients lose the ability to absorb certain vitamins and minerals adequately, requiring **lifelong supplementation**. This is a frequent NLE topic and a real clinical priority. **Key Micronutrient Deficiencies (and recognition):** 1. **Iron deficiency:** - **Common after bypass** (bypasses proximal duodenum, where iron is absorbed). - **Signs:** microcytic anemia (low MCV), fatigue, pallor, dyspnea, tachycardia, **koilonychia** (spoon-shaped nails from chronic deficiency). - **Management:** ferrous sulfate 325 mg (65 mg elemental iron) once or twice daily, ideally on an empty stomach (better absorption); many patients tolerate it better with food. Some require IV iron infusion if oral absorption is inadequate. - **Monitoring:** serum ferritin, TIBC, serum iron, hemoglobin annually; more often if symptomatic. 2. **Vitamin B12 deficiency:** - **Very common after bypass** (B12 is normally absorbed in the terminal ileum, and the intrinsic factor from the stomach is bypassed). - **Signs:** macrocytic anemia (elevated MCV), glossitis, paresthesia (tingling in hands/feet), ataxia (gait disturbance from subacute combined degeneration of spinal cord), cognitive changes, fatigue. - **Management:** B12 supplementation is **non-negotiable**. Oral tablets (cyanocobalamin 500–1000 mcg daily or weekly) or **intramuscular injections** (cyanocobalamin 1000 mcg every 3 months—preferred in bypass patients for assurance of absorption). Intrinsic factor is bypassed, so IM injections are often required. - **Monitoring:** serum B12, methylmalonic acid, homocysteine annually. 3. **Folate deficiency:** - **Common** (folate is absorbed throughout the small bowel, partially bypassed). - **Signs:** macrocytic anemia, glossitis, fatigue, impaired wound healing. - **Management:** folic acid 400–800 mcg daily (often included in multivitamins). - **Monitoring:** serum folate level annually. 4. **Calcium and Vitamin D deficiency:** - **Very common** (calcium and vitamin D are absorbed in the proximal small bowel, partially bypassed; hypochlorhydria—low stomach acid from bariatric changes—reduces calcium solubility and absorption). - **Signs:** **bone pain, osteomalacia** (soft bones, pathologic fractures), **secondary hyperparathyroidism, tetany** (muscle spasms and cramping from hypocalcemia), dental problems. - **Management:** **calcium citrate** 1000–1500 mg daily (citrate is better absorbed in low-acid environment than carbonate) + **vitamin D3 (cholecalciferol)** 1000–2000 IU daily or higher depending on baseline vitamin D status and post-operative labs. Divided doses of calcium improve absorption. - **Monitoring:** serum calcium, phosphate, magnesium, vitamin D (25-OH cholecalciferol), alkaline phosphatase, parathyroid hormone annually; some centers recommend DEXA (bone density) scans every 2–5 years. 5. **Thiamine (Vitamin B1) deficiency:** - **Important after bariatric surgery, especially in patients with vomiting** (thiamine is water-soluble and lost in diarrhea/vomiting; stores deplete quickly). - **Signs:** **Wernicke encephalopathy** (acute: confusion, ophthalmoplegia, ataxia—a medical emergency) or **wet beriberi** (high-output cardiac failure, pulmonary edema). - **Management:** thiamine 100–300 mg daily or weekly (higher doses post-op); sometimes given by IM injection if deficiency is severe or vomiting is present. - **Monitoring:** clinical assessment and thiamine level (if available) annually. 6. **Zinc deficiency:** - **Moderately common** (zinc is absorbed throughout the small bowel). - **Signs:** alopecia (hair loss), dermatitis (skin rash, often perioral or perianal), diarrhea, impaired taste (hypogeusia), impaired wound healing. - **Management:** zinc 15–25 mg daily (as part of a multivitamin or separate supplement). - **Monitoring:** serum zinc level annually if symptomatic; clinical assessment for skin/hair changes. 7. **Vitamin A deficiency (less common but possible):** - Leads to **night blindness** (nyctalopia), dry skin, impaired immune function. - Managed by ensuring adequate multivitamin (many bariatric formulations include vitamin A). 8. **Vitamin C deficiency:** - Uncommon with proper supplementation. - **Signs:** poor wound healing, bleeding gums (scurvy). - Managed by multivitamin inclusion. **Bariatric-Specific Multivitamin Formulations:** Many commercial multivitamins are **insufficient** for post-bariatric patients because they are too large to swallow (post-op), contain inadequate micronutrient concentrations, or are in wrong forms (e.g., calcium carbonate instead of citrate). **Bariatric-specific multivitamins** (e.g., Bariatric Advantage, Celebrate, Bariatric Fusion) are formulated with: - Small, liquid, or chewable forms (easier to swallow). - Calcium citrate in adequate amounts (1000–1500 mg). - Vitamin D3 (1000–2000 IU). - Cyanocobalamin (B12) or methylcobalamin (higher dose, 500–1000 mcg). - Thiamine, folate, B6, and other B vitamins. - Iron (in bypass patients), zinc, copper, selenium. - Vitamin A, C, D, E, K in therapeutic doses. Patients are counseled to **take a bariatric-specific supplement for life**. Non-adherence is a major reason for post-bariatric micronutrient deficiencies and complications. In the Philippines, these specialized supplements may be expensive; patient education about the importance of supplementation and assistance with cost (via insurance, hospital programs, or community health resources) is part of post-bariatric nursing care. **Long-Term Follow-Up:** - Annual nutritional labs: CBC (check for anemia), comprehensive metabolic panel (electrolytes, kidney/liver function), iron studies, vitamin B12, folate, vitamin D, calcium, phosphate, magnesium, zinc (if deficiency suspected), thiamine (if deficiency suspected). - Nutritionist follow-up: 6 weeks post-op, then 3 months, 6 months, 1 year, and annually thereafter. The dietitian adjusts supplementation based on labs and symptoms. - Dental follow-up: Bariatric patients have higher rates of tooth decay and gum disease (from potential acid reflux post-bypass, nutritional deficiencies affecting tooth enamel and gums); annual dental exams are recommended. - Screening for secondary complications: Endoscopy (if reflux symptoms) to screen for Barrett esophagus, bone density scans for osteoporosis, and periodic assessment for depression (post-operative weight loss can unmask or trigger depression).

As a Filipino BSN graduate and licensed nurse under RA 9173, your scope of practice in nutritional and metabolic support is well-defined and regulated. Understanding this legal and professional context ensures ethical, competent care delivery in Philippine health facilities. **RA 9173 (The Philippine Nursing Act of 2002): Key Provisions in Nutritional Support** 1. **Scope of Nursing Practice:** The law defines nursing as a profession whose primary functions are care, cure, and rehabilitation. Within this scope, nurses are authorized to: - **Assess** nutritional status (anthropometric, biochemical, clinical/dietary history). - **Plan and implement** nutritional interventions (enteral feeding, patient education, monitoring). - **Collaborate** with physicians, dietitians, and other healthcare professionals on the nutritional care team. - **Evaluate** patient response to nutritional interventions. 2. **Legal Responsibilities and Accountability:** - Nurses are **legally accountable** for their nursing actions. Failure to verify tube placement before feeding, abrupt cessation of TPN, or neglecting to monitor electrolytes in a refeeding patient are examples of **negligence** that could result in patient harm and legal consequences. - **Documentation:** All nutritional assessments, interventions (feeds given, TPN rate, GRV checks, labs reviewed), and patient responses must be clearly documented in the medical record. This is both a legal requirement and a communication tool for the healthcare team. - **Informed consent:** Before initiating enteral or parenteral nutrition, the patient (or legal guardian) must be informed of the indication, procedure, risks, and benefits. Consent is documented. 3. **Professional Standards and Competence:** - Nurses are expected to maintain **clinical competence** in nutritional support. This includes: - Knowledge of nutritional assessment and NLE-level content (as you are preparing). - Practical skills: tube placement verification, feeding pump operation, aseptic technique for TPN administration, complication recognition. - Continuing education: attending in-service training in your hospital/clinic on new nutritional guidelines, bariatric care, or emerging complications. 4. **Delegation and Supervision (NCM Levels):** - Under RA 9173, Registered Nurses may delegate certain tasks to nursing aids/health workers (e.g., assisting with oral feeding, positioning). However, the nurse **retains accountability** for oversight. Tasks requiring nursing judgment (tube placement verification, TPN monitoring, assessing for aspiration signs) cannot be delegated; the nurse must perform them. - In a tertiary hospital, a nutritionist or dietitian takes the lead in detailed nutritional planning, but the nurse is responsible for **implementation and monitoring** at the bedside. **Philippine Healthcare Delivery Context** Understanding the Filipino healthcare landscape shapes practical nursing strategies: 1. **Resource Variability:** - **Tertiary hospitals (e.g., Philippine General Hospital, National Kidney and Transplant Institute):** Well-equipped with nutritional support (PEG placement, TPN compounding in-house, dietitian services, nutritional laboratories). - **Secondary hospitals (e.g., provincial hospitals, city hospitals):** May have limited access. Tube feeding and basic TPN are available; bariatric surgery is rare. Nutritional care relies more on enteral feeding and oral supplementation with locally available, affordable foods. - **Primary health centers (barangay health centers):** Limited to screening and basic education. Malnourished patients are referred to higher levels. Oral supplementation uses local foods (eggs, fish, legumes, milk) rather than commercial formulas. 2. **Economic and Social Factors Affecting Nutrition:** - **Food insecurity:** A major driver of malnutrition in the Philippines. Many patients cannot afford adequate protein, fruits, or vegetables. Nursing assessment must include socioeconomic screening and linkage to social services, food assistance programs, or community health initiatives. - **Cultural food preferences:** Filipino patients may be reluctant to try unfamiliar foods or commercial supplements. Nutrition education should be **culturally tailored**—e.g., teaching patients to combine affordable local foods (rice + legumes + tinapa—dried fish) to create nutritious meals, rather than prescribing expensive imported supplements. - **Family support:** In Filipino culture, family is central to patient care. Involve family members in feeding and monitoring; educate them about the nutritional support plan. 3. **Obesity and Malnutrition as Dual Burdens:** - The Philippines faces a **paradoxical nutrition problem:** rising obesity (especially in urban, higher-income populations) coexists with persistent malnutrition (in rural and low-income areas). Some individuals even present with **overweight/obesity PLUS micronutrient deficiency** (e.g., a 40-year-old woman with BMI 29 but iron-deficiency anemia from poor diet quality). - Nurses must assess BOTH macronutrient and micronutrient status, avoiding the assumption that an overweight patient is well-nourished. 4. **Infectious Disease Considerations:** - **Tuberculosis (TB)** is endemic in the Philippines and increases nutritional demands. Patients on anti-TB drugs may experience appetite loss or drug interactions with nutritional supplements. Close nutritional monitoring and counseling are essential. - **HIV/AIDS:** Still prevalent; patients may face severe malnutrition from malabsorption and wasting syndrome. Nutritional support is central to antiretroviral therapy success. - **Infection control in enteral feeding:** In resource-limited settings, contamination of tube feeding (from non-sterile technique or lack of refrigeration) can cause diarrhea and sepsis. Emphasize hand hygiene, clean (not necessarily sterile) technique, and appropriate formula storage. **Nursing Leadership and Advocacy** 1. **Assessment and Early Intervention:** - Screen all patients, especially those at risk (elderly, chronic disease, post-operative, cancer, poverty). Early identification of malnutrition allows intervention before severe complications develop. - Document nutritional status clearly; alert the physician and dietitian if a patient is losing weight or has low prealbumin—these warrant nutritional support. 2. **Education and Prevention:** - Teach patients and families about balanced nutrition using **affordable local foods** and practical cooking methods. - Emphasize that obesity and malnutrition are both preventable through gradual, sustainable behavior change—not crash dieting. - For bariatric surgery patients, emphasize **lifelong supplementation** and regular follow-up; don't minimize the long-term commitment. 3. **Advocacy for Vulnerable Populations:** - In resource-limited settings, patients may lack funds for nutritional supplements. Advocate for hospital/clinic policies that provide basic nutritional support (oral supplements) to indigent patients, or work with social services to connect patients to assistance programs. - For bariatric surgery, ensure equitable access—not only for those who can afford private hospital care, but also through public hospitals. 4. **Quality and Safety:** - Implement and adhere to hospital protocols for tube placement verification, TPN administration, and enteral feeding safety. These are evidence-based and protect patients. - Report near-misses and adverse events (e.g., tube-feeding aspiration, TPN CRBSI) transparently; use these to improve systems (e.g., standardized tube-placement verification checklists, dedicated TPN lines). - Participate in nutrition support teams if your facility has one; this interprofessional approach optimizes outcomes.